Authors: Ratanatharathorn, V Ayash, L Lazarus, HM Fu, J Uberti, JP

Citation: V. Ratanatharathorn et al., Chronic graft-versus-host disease: clinical manifestation and therapy, BONE MAR TR, 28(2), 2001, pp. 121-129

Authors: Cronin, S Uberti, JP Ayash, LJ Raith, C Ratanatharathorn, V

Citation: S. Cronin et al., Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation, BONE MAR TR, 26(11), 2000, pp. 1247-1249

Authors: Ratanatharathorn, V Carson, E Reynolds, C Ayash, LJ Levine, J Yanik, G Silver, SM Ferrara, JLM Uberti, JP

Citation: V. Ratanatharathorn et al., Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease, ANN INT MED, 133(4), 2000, pp. 275-279

Authors: Uberti, JP Cronin, S Ratanatharathorn, V

Citation: Jp. Uberti et al., Optimum use of tacrolimus in the prophylaxis of graft versus host disease, BIODRUGS, 11(5), 1999, pp. 343-358

Authors: Przepiorka, D Devine, SM Fay, JW Uberti, JP Wingard, JR

Citation: D. Przepiorka et al., Practical considerations in the use of tacrolimus for allogeneic marrow transplantation, BONE MAR TR, 24(10), 1999, pp. 1053-1056